Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Össur will be carbon neutral in 2021

Company On Track to Achieve Environmental Milestone During 50[th] Anniversary YearREYKJAVIK, Iceland, February 10, 2021 – Össur (Nasdaq:OSSR), a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking innovations, announced today that the company will be carbon neutral in 2021, its 50[th] anniversary year. Originally founded in February 1971, the company has demonstrated successful growth since its initial public listing in 1999. A leading innovator in the prosthetics and bracing and supports field, Össur has been actively working towards a

SOTKAMO SILVER AB: Q4/2020 RELEASE AND WEB CAST

Press release: Stockholm, February 10, 2021 15:00 CETSotkamo Silver AB will release Q4/2020 results on February 17, 2021 around 08:45 CET. The webcast to the investors will be held on February 17, 2021, at 14:00 Finnish time via a Teams-meeting. You can register for the meeting on the company's website at: www.silver.fi/fi/sijoittajat/ilmoittaudu We will send registration instructions and a link to the event to those who have registered before the event. Please, make your registration by February 16, 2021. The presentation will be in Finnish, and the material is in English. The

Medivir enters into licensing agreement with Ubiquigent for preclinical program USP7

Stockholm, Sweden— Medivir AB (Nasdaq Stockholm: MVIR) announced today that it had entered into a license agreement with Ubiquigent Limited (Ubiquigent) for Medivir’s preclinical USP7 research program. Under the terms of the agreement, Medivir has granted Ubiquigent an exclusive worldwide license to develop and commercialize the program including all associated compounds across any therapeutic indication(s) in return for agreed revenue share upon successful development or commercialization by Ubiquigent. Ubiquitin specific peptidase 7 (USP7) is a deubiquitylating (DUB) enzyme that has

Cint publishes prospectus and announces price range for its initial public offering on Nasdaq Stockholm

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, JAPAN, CANADA, AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE.For complete press release please refer to: https://investors.cint.com/en/ipo For more information, please contact: Joakim Andersson, CFOTel: +46 760 44 8330Email: joakim.andersson@cint.com Patrik Linzenbold, Head of IRTel: +46 708 252

Year-end report 2020: Strong growth in sales and profit

Fourth quarter 2020: · Sales increased to SEK 2,487 million (2,296) · Operating profit (EBITA) rose to SEK 283 million (249) · Profit after tax was SEK 211 million (206) · Diluted earnings per share increased to SEK 7.87 (7.75) · Cash flow after investments was SEK 211 million (SEK 601 million excl. acquisitions) · The equity/assets ratio was 43% (48), with net financial liabilities of SEK 298 million (net assets of SEK 666 million) · The Board proposes a dividend of SEK 16.00 (0.00) per share · The Board proposes a 10:1 share split “Nolato continued to perform

OncoZenge has been approved for listing on Nasdaq First North Growth Market

OncoZenge AB (publ) has today obtained approval from Nasdaq Stockholm for admission to trading on Nasdaq First North Growth Market. The first day of trading in OncoZenge's shares will be on Friday, February 12, 2021.THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY

NOTICE OF EXTRAORDINARY GENERAL MEETING OF ACROUD AB (PUBL)

This is a translation of the Swedish original. In case of discrepancies between this English translation and the Swedish original, the latter shall prevail. Press Release10 February 2021The shareholders of Acroud AB (publ), 556693-7255 (”Company”), are hereby given notice of the Extraordinary General Meeting on Monday 1 March 2021 to be held by postal voting only. By reason of the transmission of the coronavirus, the board of directors has decided that the extraordinary general meeting (EGM) will be held by postal voting ahead of the meeting, in accordance with temporary legislation.

Invitation to the presentation of John Mattson’s year-end report for 2020, on 24 February at 10:00 a.m. (CET)

Invitation by John Mattson to the teleconference and webcast on 24 February at 10:00 a.m. (CET) being held in conjunction with the publication of the company’s year-end report at 8:00 a.m. (CET) the same date.Investors, asset managers, equity analysts, the press and other stakeholders are invited to participate in the conference, where CEO Siv Malmgren and CFO Maria Sidén will present the year-end report for 2020. No advance notice of attendance is required. Following the presentation, it will be possible to ask questions. The presentation starts at 10:00 a.m. (CET) and will be held in

Elekta’s ProKnow to help standardize radiotherapy for veterans

Cloud-based ProKnow will enable peer review across Veterans Affairs networkATLANTA, February 10, 2021 – Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with Elekta’s (EKTA-B.ST) ProKnow , a web browser-based cloud solution that centralizes radiotherapy data in a secure scalable platform accessible to all 41 of the VA’s radiation oncology facilities nationwide. “ProKnow is designed to give caregivers the ability to evaluate massive

Orexo starts to test modia™ on patients in collaboration with ApexB.io and Magellan Rx Management

·The Covid-19 pandemic has highlighted the urgent need for additional resources to prevent overdose deaths, which have reached an all-time high[[[1]]] · modia™ can help those with opioid use disorder by providing access to quality, evidence-based interventions and behavioral health servicesMORRISTOWN, NJ, US, February 10, 2021: Orexo, a Swedish pharmaceutical company,will collaborate with ApexB.io and Magellan Rx Management to further research on the use of modia™, a digital therapeutic designed for individuals with opioid use disorder (OUD), by establishing a novel, real-world

Arcus ASA: Invitation to presentation of Arcus' fourth quarter 2020 results, Wednesday 17 February

Arcus will report its fourth quarter 2020 results on Wednesday 17 February 2021 at 08.00 CET. The quarterly report and the presentation material will be available at https://www.arcus.no/en/investor. As a consequence of the Covid-19 pandemic, there will not be a physical presentation of the results. Instead, we invite to a live Teams-meeting Wednesday 17 February at 08.00 CET. You can join the presentation here 

Cantargia reports first patient treated in CANFOUR pancreatic cancer phase IIa extension cohort

Cantargia AB today announced that the first patient with pancreatic cancer (PDAC) has started treatment in the phase IIa extension part of the CANFOUR trial, investigating combination of CAN04 and chemotherapy. The extension part has been designed to provide additional information complementing the primary cohort of 31 patients. Nine of these patients are still being treated, providing additional information on long term efficacy and safety. Important efficacy parameters such as progression free survival and duration of response are planned to be evaluated for the primary cohort during H1

Notification of Executives’ transactions with Vestas shares

Vetas Wind Systems A/S, Aarhus, 10 February 2021Company announcement no. 02/2021   Notification of Executives’ transactions with Vestas shares In accordance with Article 19 (3) of the EU Market Abuse Regulation, Vestas Wind Systems A/S is required to disclose information regarding trading in Vestas Wind Systems A/S shares and securities by Executives and persons closely associated with an Executive. This notification concerns performance shares vested to Executives on 10 February 2021 in accordance with Vestas’ share-based incentive programme, ref. Company announcement no. 17/

Veriff Expands Access to Identity Verification with Improved Self Serve Platform

Veriff, a leading global identity verification (IDV) provider, today announced the launch of its improved identity verification-as-a-service platform, expanding access to its intelligent decision engine for small and medium-sized businesses (SMB).The Self Serve platform is available in three tiers, starting at $49 per month, and is the first self-service model to provide access to enterprise-level risk labeling — critical data that provides insight into the signs of fraudulent behavior of individual verifications. With this type of insight and data, including a video of the verification

Multiconsult ASA (OSE: MULTI): Presentation of fourth quarter and full year 2020 results on 17 February 2021

Multiconsult hereby invites you to the presentation of the results for the fourth quarter and full year 2020 results.The results will be presented in Norwegian at 08:30 (CET) through a live webcast. Participants will have the opportunity to submit questions online throughout the webcast session. An English presentation will be made at 09:30 (CET), followed by a Q&A session. The presentations will be held by CEO Grethe Bergly and CFO Hans-Jørgen Wibstad. Live webcasts, complete report and presentation will be available on https://www.multiconsult-ir.com. The Norwegian presentation at 08:

AAK appoints Gabriella Grotte as Head of Investor Relations and Corporate Communications

To further strengthen its Investor Relations activities and respond to the growing interest in the company, AAK AB (publ.) has appointed Gabriella Grotte as Head of Investor Relations and Corporate Communications. Gabriella joins AAK with a solid Investor Relations and Communications background. During the past thirteen years she has worked for Swedish company Alfa Laval AB, a leading global provider of heat transfer, separation and fluid handling products and solutions. For twelve of those years she has served as Investor Relations Manager. Aside from holding other senior positions

OssDsign’s year-end results to be presented via webcast

OssDsign AB (publ) (“OssDsign” or the “Company”) will present their upcoming year-end report live via Finwire TV WebcastOssDsign will be publishing the year-end report 2020 tomorrow Thursday February 11th at 08:00 CET. Later tomorrow, the results will also be presented live by CEO Morten Henneveld via a webcast in cooperation with Finwire Media. The webcast, which will run from 10:00 CET tomorrow February 11th, can be followed via the link https://www.finwire.tv/webcast/ossdsign/q4/ 

Public transport ticketing is now easier with Fidesmo Pay

On February 2, it became possible for Stockholm residents to tap their payment card against the ticket reader and pay for a ticket for the public transport network. And with this, the payment service Fidesmo Pay also became an approved alternative as you can tap your wearable instead of your payment card when traveling in Stockholm.The Swedish tech company Fidesmo makes it possible to connect contactless services, such as payment and public transport ticketing, to a variety of devices, such as wearables. The payment service Fidesmo Pay can now be used when traveling on public transport in

Company Announcement No. 15, 2021 - Results of the auctions of covered mortgage bonds in Nordea Kredit Realkreditaktieselskab

Nordea Kredit Realkreditaktieselskab has auctioned covered mortgage bonds to refinance ARMs as per 1 April 2021 on 9 and 10 February 2021. The auction results are presented in the pdf file attached. For more detailed information please contact Nordea, Long Term Funding, Peter Brag at +45 33 33 16 63 and Lau Kingo at +45 33 33 17 51. Yours faithfully Nordea Kredit Realkreditaktieselskab

Invitation to telephone conference for Year-end report January – December 2020

Mekonomen’s Year-end report January - December 2020 will be published on Friday, 12 February, at 07:30 a.m CET. A telephone conference will be held on the same day at 09:00 a.m CET in English. Mekonomen's CEO Pehr Oscarson and CFO Åsa Källenius will present the results and respond to questions at the English speaking conference. The presentation material will be available from 8:00 a.m CET on 12 February at www.mekonomen,com under the heading Investors/IR Presentations.   Click this link to

East Capital Real Estate makes major acquisition and enters real estate development market

East Capital Real Estate has acquired 30 hectares of land outside of Tallinn for a new logistics project. The land is located in the corner of the Tallinn ring road and the Tartu highway, which is a high-value location for logistics, distribution, and light industry companies in the Estonian capital. It is also well connected to the main highways and has good connection with public transport, being located in close proximity to where IKEA is establishing a new store. The building right is for 150,000 sqm of logistics facilities with detailed planning in place and can thus be considered

EQT Private Equity exits Flying Tiger Copenhagen

· EQT Private Equity divests Flying Tiger Copenhagen to the investment firm Treville  · Since EQT Private Equity’s entry in 2013, Flying Tiger Copenhagen has grown from around 200 stores in 16 European countries to more than 900 stores across 27 countries in Europe and Asia. The number of full-time employees has increased from around 1,000 to approximately 6,000  · The management team, led by CEO Martin Jermiin and CFO Christian Kofoed Jakobsen, spearheaded a successful turnaround in 2019 increasing EBITDA by more than 50 percent and was expecting an all-time high EBITDA going

Successful production start of OXE300 in Poland

The first OXE300 has been assembled and shipped from PanLinks Polish site at the special economic zone of Tczew.The development of the production set up for the OXE300 advances according to plan, well in line with the previously communicated goal to start production of OXE300 in Tczew (Poland) under the first quarter this year. Assembly of the first three units has recently been finalized and are waiting to be shipped out. Two more units are expected to be finalized before this weeks end. OXE Marine AB (NASDAQ STO: OXE) (OTCQB: CMMCF) personnel are on site to align the production process

INVITATION TO PRESENTATION OF Q4-2020 FINANCIAL RESULTS

Date rectification: the release this morning referred the date for the earnings release on 17 February 2010, this should be 17 February 2021. Oslo, Norway (10 February 2021) — NattoPharma will release its fourth quarter financial results on Wednesday 17[th] February 2021 at approximately 07:00 CET. The report will be made available at www.nattopharma.com and at www.oslobors.no. The same day, starting at 10:00 am, the company will host a webcast with a presentation of the results followed by an online Q&A session. Please follow the below link to join the web-cast, https://channel.

There are no items matching the current filter
There are no more items matching the current filter
Back to top